Zobrazeno 1 - 10
of 43
pro vyhledávání: '"Charles Ming Lok Chan"'
Autor:
Anthony Tak Cheung Chan, Thomas Chi Chuen Au, Money Yan Yee Lam, Amanda Kit Ching Chan, Elena Siu Fong Lo, Moon Tong Cheung, Paul Bo San Lai, Simon Siu Man Ng, Edwin Pun Hui, Brigette Buig Yue Ma, Charles Ming Lok Chan, Sze Chuen Cesar Wong
Purpose: Current immunomagnetic enrichment method can only detect general epithelial antigens of circulating tumor cells (CTC). Further characterization of the CTCs to provide specific information on the tumor type is not possible. We attempted to ov
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::731c6147ae4001a3ada0d70b519e3baa
https://doi.org/10.1158/1078-0432.c.6517642
https://doi.org/10.1158/1078-0432.c.6517642
Autor:
Anthony Tak Cheung Chan, Thomas Chi Chuen Au, Money Yan Yee Lam, Amanda Kit Ching Chan, Elena Siu Fong Lo, Moon Tong Cheung, Paul Bo San Lai, Simon Siu Man Ng, Edwin Pun Hui, Brigette Buig Yue Ma, Charles Ming Lok Chan, Sze Chuen Cesar Wong
Supplementary Tables S1-S3 from Clinical Significance of Cytokeratin 20-Positive Circulating Tumor Cells Detected by a Refined Immunomagnetic Enrichment Assay in Colorectal Cancer Patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b99221047a192fe4ce75a6ab7046445
https://doi.org/10.1158/1078-0432.22440292
https://doi.org/10.1158/1078-0432.22440292
Autor:
Sze Chuen Cesar Wong, Catherine Wan He, Charles Ming Lok Chan, Amanda Kit Ching Chan, Heong Ting Wong, Moon Tong Cheung, Lewis Lai Yin Luk, Thomas Chi Chuen Au, Man Kin Chiu, Brigette Buig Yue Ma, Anthony Tak Cheung Chan
Publikováno v:
PLoS ONE, Vol 8, Iss 11, p e79481 (2013)
Frizzled homolog 3 receptor was up-regulated in several gastrointestinal cancers such as esophageal and gastric cancers. Moreover, frizzled homolog 3 has recently reported to be expressed in colorectal adenoma specimens. In the present study, we inve
Externí odkaz:
https://doaj.org/article/f49ed54542974856b9188894e9acc707
Autor:
WAN HE1, CHARLES MING LOK CHAN2, SZE CHUEN CESAR WONG3 cesar.wong@polyu.edu.hk, THOMAS CHI CHUEN AU2, WING SHAN HO2, AMANDA KIT CHING CHAN4, ANDREW SAI KIT CHAN2, BRIGETTE BUIG YUE MA2, ANTHONY TAK CHEUNG CHAN2 anthony@clo.cuhk.edu.hk
Publikováno v:
Oncology Letters. Dec2016, Vol. 12 Issue 6, p5193-5198. 6p.
Autor:
Ann D. King, Charles Ming Lok Chan, Wing M. Ho, Anthony T.C. Chan, A. Poon, Linda K.S. Leung, Frankie Kf Mo, Sze Chuen Cesar Wong, Ki Wang, Brigette B.Y. Ma
Publikováno v:
Annals of Oncology. 28:1576-1581
Background This study investigated the predictive and prognostic significance of assessing early drug response with both positron-emission computerized tomography (PET-CT) and circulating tumor cells (CTCs) in patients receiving first-line chemothera
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea5164e1636735060d59633c0e7aabe3
https://doi.org/10.1093/annonc/mdx149
https://doi.org/10.1093/annonc/mdx149
Autor:
W. C. Cho, Vivian Weiwen Xue, Sze Chuen Cesar Wong, Lawrence W. C. Chan, Charles Ming Lok Chan, Thomas Chi Chuen Au, Hin Fung Tsang, Yin Kwan Evelyn Wong
Publikováno v:
Expert Review of Precision Medicine and Drug Development. 2:177-186
Introduction: Polymerase chain reaction (PCR) has been a reliable molecular technology in both research and clinical fields for decades. It amplifies a minute amount of DNA or RNA sample into large quantity for target detection. Recently, a more adva
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::92f3d5c8f9ef148ea4efba1a2b0da128
https://doi.org/10.1080/23808993.2017.1347482
https://doi.org/10.1080/23808993.2017.1347482
Autor:
Amanda Kit Ching Chan, Sze Chuen Cesar Wong, Brigette B.Y. Ma, Wing Shan Ho, Anthony T.C. Chan, Thomas Chi Chuen Au, Charles Ming Lok Chan, Wan He, Andrew Sai Kit Chan
Publikováno v:
Oncology Letters. 12:5193-5198
Although the Notch pathway has been reported to be activated in colorectal cancer (CRC), limited information is available regarding the expression and role of its ligand, Jagged 2 (JAG2), in CRC. Using immunohistochemistry, the present study demonstr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::85b8ab9c9817e2b83659292be28b292c
https://doi.org/10.3892/ol.2016.5321
https://doi.org/10.3892/ol.2016.5321
Autor:
Rosalie Ho, V. Lee, Cesar Sze-chuen Wong, Brigette B.Y. Ma, Anthony W.H. Chan, Michael K.M. Kam, Wai Tong Ng, Ka Fai To, Anthony T.C. Chan, Roger K.C. Ngan, Herbert H. Loong, Sing Fai Leung, Ashley Cheng, Frankie Mo, Stephen L. Chan, Edwin P. Hui, Charles Ming Lok Chan, Stewart Y. Tung, K.C. Allen Chan
Publikováno v:
Cancer. 121:2720-2729
BACKGROUND Single nucleotide polymorphism (SNP) of the excision repair cross-complementing group 1 (ERCC1) gene has been linked with sensitivity to platinum and radiation. The authors hypothesized that the ERCC1 genotype for the SNPs cytosine-to-thym
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f6c808ecbeb6a69055d77f8931aeb565
https://doi.org/10.1002/cncr.29413
https://doi.org/10.1002/cncr.29413
Autor:
Thomas Chi Chuen Au, Elaine Yue Ling Wong, Amanda Kit Ching Chan, Vivian Wai Yan Lui, Chi Man Tsang, Sai Wah Tsao, Charles Ming Lok Chan, Cecilia Pik Yuk Lau, Anthony T.C. Chan, Emily K.Y. Lam, Louisa Yeung Ho, Sze Chuen Cesar Wong
Publikováno v:
Oncology Letters
The TP53induced glycolysis and apoptosis regulator (TIGAR) is the protein product of the p53 target gene, C12orf5. TIGAR blocks glycolysis and promotes cellular metabolism via the pentose phosphate pathway; it promotes the production of cellular nico
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5bcb296d8a004bdf99a9f13689da6e34
https://doi.org/10.3892/ol.2014.2797
https://doi.org/10.3892/ol.2014.2797
Autor:
C.H. Wong, Anthony T.C. Chan, Frankie Mo, Leung Li, Brigette B.Y. Ma, Ann D. King, Charles Ming Lok Chan, Herbert H. Loong, Edwin P. Hui, Anil T. Ahuja, Connie W.C. Hui, Ki Wang
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 24(5)
Purpose: We hypothesized that axitinib is active with an improved safety profile in nasopharyngeal carcinoma (NPC).Experimental Design: We evaluated axitinib in preclinical models of NPC and studied its efficacy in a phase II clinical trial in recurr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93b8de25686014800d9f2e2f567cd1ba
https://pubmed.ncbi.nlm.nih.gov/29301831
https://pubmed.ncbi.nlm.nih.gov/29301831